Novo Nordisk A/S (CPH: NOVO.B)

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of 3.28 trillion as of November 21, 2024. Its market cap has increased by 4.15% in one year.

• Market Cap: 3.28T
• Enterprise Value: 3.26T
• Revenue: 270.58B
• Ranking: n/a
• PE Ratio: 34.81
• Stock Price: 721.80

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 3.28T, an increase of 7,029.09%. That is a compound annual growth rate of 16.61%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	3,265.89B	4.93%
Dec 29, 2023	3,112.33B	46.89%
Dec 30, 2022	2,118.80B	26.50%
Dec 30, 2021	1,674.99B	69.77%
Dec 30, 2020	986.61B	8.50%
Dec 30, 2019	909.35B	27.49%

Related Stocks

Company	Market Cap
Coloplast A/S	201.09B
Genmab A/S	91.84B
Demant A/S	57.65B
Zealand Pharma A/S	47.79B
H. Lundbeck A/S	41.79B
H. Lundbeck A/S	41.53B
ALK-Abelló A/S	34.15B
Ambu A/S	30.12B